Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: A randomized open-label trial

This randomized open-label trial was designed to provide preliminary immunogenicity and safety data to support development of the pediatric 13-valent pneumococcal conjugate vaccine (PCV13) for adults. The aims were to: identify an age-appropriate PCV13 formulation, i.e., with (n = 309) or without (n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Juergens, Christine, de Villiers, Pierre JT, Moodley, Keymanthri, Jayawardene, Deepthi, Jansen, Kathrin U, Scott, Daniel A, Emini, Emilio A, Gruber, William C, Schmoele-Thoma, Beate
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896606/
https://ncbi.nlm.nih.gov/pubmed/24576885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.27998
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars